Massive Pharmaceuticals Private Limited
About Massive Pharmaceuticals Private Limited
Data last updated:
Massive Pharmaceuticals Private Limited is a private limited company based in Trichy, Tamil Nadu, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 July 2006 and has been in existence for over 20 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2006PTC060577. Its GSTIN is 33AAECM9174G1ZC (Tamil Nadu).
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹16 Lakh. It is led by directors Govindarajan Mohan and Pappaian Arun Prasath.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Trichy, Tamil Nadu.
As per the financials filed for FY 2024, the company reported a revenue of ₹5.72 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹3.74 Lakh (net margin 0.7%) and EBITDA of ₹58.53 Lakh (EBITDA margin 10.2%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 7% over five years.
The company has about 18 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹1.79 Cr and satisfied charges of ₹1 Cr on record. Court records list 1 case involving the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No: 7 Old No: 11 New No: 45 Ground Floor 1st Floor J.P. Nagar 5th Cross Karuman, Dapam., Trichy, Tamil Nadu, India – 620001
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Massive Pharmaceuticals Private Limited
The main business activity of Massive Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals Private Limited is audited by 7B HOLY CROSS COMPLEX for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| 7B HOLY CROSS COMPLEX | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajan Mohan | Director | 18 Jul 2006 | 20 Years 2 Months | Current |
| Pappaian Arun Prasath | Director | 18 Jul 2006 | 20 Years 2 Months | Current |
Financials of Massive Pharmaceuticals Private Limited FY 2024 filings available
Massive Pharmaceuticals Private Limited reported revenue of ₹5.72 Cr (up 2% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Massive Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 7% over five years, including 2% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Massive Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹58.53 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹3.74 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Massive Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Massive Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Massive Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Massive Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2024 | Hdfc Bank Limited | ₹10.53 Lakh | Open |
| 18 Mar 2024 | Hdfc Bank Limited | ₹15.81 Lakh | Open |
| 30 Jan 2021 | Hdfc Bank Limited | ₹11.26 Lakh | Open |
| 30 Jan 2021 | Hdfc Bank Limited | ₹11.78 Lakh | Open |
| 02 Aug 2016 | Others | ₹1.3 Cr | Open |
Total charge records: 7 View all charges
Employees and EPFO Compliance at Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals Private Limited has a workforce of 18 employees as of Mar 22, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAECM9174G1ZC | Tamil Nadu | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Legal Cases of Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals Private Limited has 1 court case on record: 1 where it is another party. All case is pending. Status as checked on 21 Sep 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Salem, Tamil Nadu | Criminal miscellaneous application | Company is another party | Pending |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit Ratings, Litigation & Regulatory Alerts for Massive Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Massive Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Massive Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Massive Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Massive Pharmaceuticals Private Limited
Frequently Asked Questions about Massive Pharmaceuticals Private Limited
Massive Pharmaceuticals is an active private limited company based in Trichy, Tamil Nadu, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 July 2006 (20+ years old) and is registered under CIN U24232TN2006PTC060577.
Massive Pharmaceuticals reported revenue of ₹5.72 Cr for FY 2024 (up 2% YoY).
Massive Pharmaceuticals has 2 current directors:
- Govindarajan Mohan - Director
- Pappaian Arun Prasath - Director
Massive Pharmaceuticals reported a net profit of ₹3.74 Lakh (net margin 0.7%) and EBITDA of ₹58.53 Lakh (EBITDA margin 10.2%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Massive Pharmaceuticals is 10% over three years and 7% over five years. In the latest year (FY 2024) revenue rose 2%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Massive Pharmaceuticals is 33AAECM9174G1ZC, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Massive Pharmaceuticals is U24232TN2006PTC060577. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Massive Pharmaceuticals has 1 court case on record. 1 is pending.
Massive Pharmaceuticals was incorporated on 18 July 2006, making it 20+ years old. It is registered with the Registrar of Companies, Chennai.